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Abstract
Background: Foot problems in general and forefoot problems in particular can lead to a decrease in mobility and
a higher risk of falling. Forefoot problems increase with age and are more common in women than in men.
Around 20% of people over 65 suffer from non-traumatic foot problems and 60% of these problems are localised
in the forefoot. Little is known about the best way to treat forefoot problems in older people. The aim of this
study is to compare the effects of two common modes of treatment in the Netherlands: shoe advice and podiatric
treatment. This paper describes the design of this study.
Methods: The study is designed as a pragmatic randomised clinical trial (RCT) with 2 parallel intervention groups.
People aged 50 years and over who have visited their general practitioner (GP) with non traumatic pain in the forefoot
in the preceding year and those who will visit their GP during the recruitment period with a similar complaint will be
recruited for this study. Participants must be able to walk unaided for 7 metres and be able to fill in questionnaires.
Exclusion criteria are: rheumatoid arthritis, neuropathy of the foot or pain caused by skin problems (e.g. warts, eczema).
Inclusion and exclusion criteria will be assessed by a screening questionnaire and baseline assessment. Those
consenting to participation will be randomly assigned to either a group receiving a standardised shoe advice leaflet
(n = 100) or a group receiving podiatric treatment (n = 100). Primary outcomes will be the severity of forefoot pain
(0-10 on a numerical rating scale) and foot function (Foot Function 5-pts Index and Manchester Foot Pain and Disability
Index). Treatment adherence, social participation and quality of life will be the secondary outcomes. All outcomes will
be obtained through self-administered questionnaires at the start of the study and after 3, 6, 9 and 12 months. Data will
be analysed according to the “intention-to-treat” principle using multilevel level analysis.
Discussion: Strength of this study is the comparison between two common primary care treatments for forefoot
problems, ensuring a high external validity of this trial.
Trial registration: Netherlands Trial Register (NTR): NTR2212
Background
Pain and discomfort due to foot problems are common
and increase with age. Population-based surveys have esti-
mated the prevalence of foot problems between 14.9 and
41.9% for people aged 50 years and older [1-4]. The preva-
lence of foot problems was found to be higher in women
than in men [2,5]. Not all foot problems or foot deformi-
ties lead to pain or functional limitations [5-7] but people
with disabling foot pain have been shown to experience a
lower degree of well-being [2] and to have a higher risk of
a decrease in mobility [2,8] and falling [9,10].
Forefoot problems including metatarsalgia, hallux val-
gus and hallux rigidus are the most common foot pro-
blems in older people [2,5,9]. A community-based study
among 5689 older people in the Dutch area of Apeldoorn
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forefoot problems of 60% within the group of people
reporting non-traumatic foot problems (n = 1130) [2]. In
an English population survey among 3417 adults, more
than one-third indicated to have pain in the great toe or
in the first metatarsophalangeal joint (MTP-joint), and
9.5% indicated to be disabled by their foot problem [5].
Underreporting of foot problems is an acknowledged
phenomenon in healthcare [9-11]. The community-
based survey among older people in The Netherlands
[9] showed that only 56% of the respondents sought
health care, by consulting their general practitioner (GP)
(46%), a medical specialist (36%) (mainly orthopaedic
surgeons) or an allied health care professional (18%)
(mainly podiatrists). A GP will commonly refer non-
traumatic foot problems to a podiatrist or will treat the
patient him or herself. Dutch podiatric care starts with
an assessment which includes medical history, detailed
analysis of the anatomical relationships within the foot
and both a postural and a gait analysis [12]. Treatment
may consist of (or a combination of) construction of full
length podiatric insoles, silicone toe devices, (shoe)
advice or basic foot and nail care. The treatment by the
GP usually consists of prescribing pain medication (sim-
ple analgesic or non-steroidal inflammatory drugs
[NSAIDs]) or by giving lifestyle advice (e.g. try to lose
weight, improve shoe wear) [13].
The primary cause of non-traumatic forefoot problems
can be very diverse and includes the possible influence of
ill-fitting shoes [14,15]. Some evidence exists that ill-fitting
footwear is associated with foot problems such as corns,
calluses, hallux valgus and lesser toe deformities. Both the
advice to buy well-fitting shoes and referral to a podiatrist
are common treatment modalities of Dutch GPs. Whether
these treatments actually lead to improvement of non-
traumatic forefoot problems is not known, nor is it known
if one treatment is more effective than the other.
The aim of this article is to describe the protocol of a
pragmatic randomised clinical trial to compare the effec-
tiveness of two common treatments for forefoot problems
in older people and to discuss (or comment on) the
choices made in the design. The primary objective of the
trial is to investigate the effectiveness of podiatric treat-
ment versus standardised shoe advice in people aged
50 years and older with disabling forefoot pain. The sec-
ondary objective is to conduct a process evaluation of the
podiatric treatment provided for forefoot pain in this trial.
Method
Trial design
This study is designed as a pragmatic open randomised
clinical trial with 12 months follow-up. Participants will
be recruited via general practice clinics (figure 1); those
who are eligible and give written consent to participation
will be randomly assigned to either the intervention
group or the control group. The Medical Ethics Commit-
tee of the VU University Medical Centre in Amsterdam
has approved the design of this study (No. 2009/267).
Participants
General practice clinics affiliated with the Academic
Network for GPs of the VU University Medical Centre
in Amsterdam will partake in this study. Recruitment of
participants will be from patients who have visited their
GP with non traumatic pain in the forefoot in the pre-
ceding year and those who will visit their GP during the
recruitment period with a similar complaint. Partici-
pants, aged 50 or over, will have non-traumatic pain
around the MTP-joints (figure 2) or further distally of at
least one month’s duration. The pain will be due to a
musculoskeletal forefoot problem and the participants
indicate to be functionally disabled because of this ail-
ment. Participants will be excluded if they have received
treatment for this problem in the previous six months
or if the pain is caused by rheumatoid arthritis, a recent
trauma, an operation, or by a non musculoskeletal pro-
blem (e.g. warts or a fungal infection of the foot). Addi-
tionally, patients with diabetic neuropathy of the feet or
with foot problems that are deemed to be too serious by
either the GP or by the study team to be treated in pri-
mary care will be excluded. Patients with rheumatoid
arthritis or diabetic neuropathy are excluded from this
trial because Dutch medical guidelines [16]indicate that
these patients should be referred for podiatric care in all
cases. Participants who are not able to walk 7 meters
without a walking aid are also excluded, as they will not
be able to perform the foot pressure measurements.
Inclusion procedure
Potential participants will be recruited by three different
methods. First, in all participating practices a retrospec-
tive search of the medical records will be carried out to
identify all people aged 50 and over who have consulted
their GP for a forefoot problem in the year preceding
the start of the study. Second, all older people who con-
sult their GP for forefoot problems during a period of
12 months following the start of the study will be con-
sidered for participation (prospective recruitment).
Finally, all people visiting the general practice (for any
reason) will be informed about the study by putting up
posters in the waiting area of the GP clinics inviting
patients to contact their GP if they have forefoot pain.
All potentially eligible patients will be invited to parti-
cipate in the study and will receive comprehensive infor-
mation about the study, a screening questionnaire and
a pre-paid envelope to return the consent form and the
questionnaire. Non-responders will receive a reminder
after 2 weeks.
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exclusion criteria will be assessed using self-report infor-
mation from the screening questionnaire. Forefoot pain
intensity is scored using a 0-10 point numerical rating
scale and the location of pain is indicated on a foot
manikin [17]. The area that will lead to inclusion in the
study is shown in figure 2. Foot disability is assessed by
the Foot Pain and Disability Index (FPDI) [17,18].
All patients who are potentially eligible for the study
based on the screening questionnaire will be invited for a
foot examination details of which will be discussed below
(see Foot examination). The purpose of the foot examina-
tion is to measure baseline foot and pressure characteris-
tics and to assess eligibility to participate in the trial. If
the foot problem of the patient is considered to be too
severe, and neither podiatric treatment nor shoe advice is
considered adequate treatment, or if there are signs of
any of the exclusion criteria like diabetic neuropathy, the
patient will be referred back to their GP. If patients meet
all eligibility criteria, written consent to participation in
the trial will be obtained and a unique study number will
be allocated to the participant.
Foot examination
A foot examination will be performed at baseline before
randomisation to assess eligibility. Additionally, 25 parti-
cipants from the podiatry group will be asked to attend
a second foot examination after three months to enable
the process evaluation (see process evaluation of podia-
tric treatment). The presence of diabetic neuropathy in
Figure 1 Design of the RCT.
van der Zwaard et al. Journal of Foot and Ankle Research 2011, 4:11
http://www.jfootankleres.com/content/4/1/11
Page 4 of 8the forefoot will be ruled out based on tests using a 10
gram Weinstein monofilament and a 64 Hz tuning-fork.
With the participant having his or her eyes closed, the
skin on the plantar skin of the hallux and the MTP
joints of I and V will be touched with the monofilament,
and two out of three touches must be perceived. The
vibrating tuning-fork is placed on the medial side of
MTP1 and on the lateral side of MTP5; the vibration
must be perceived for more than 5 seconds. Digital
photographs of the ventral, lateral and medial side of
the foot and shoes will be taken on a surface containing
measurement lines in centimetres. Participants will be
asked to bring the shoes they wear most often for this
assessment and for the pressure measurements. Next,
the Foot Posture Index will be assessed and scored
according to Redmond et al. [19]. To assess pressure
distribution patterns during barefoot and shod gait
Emed-X (Novel gmbh, Münich, Germany) [20] and
Pedar-X (Novel gmbh, Münich, Germany) [21,22] will
be used. The Emed platform (4 sensors per cm2, sample
frequency 100 Hz) is imbedded in a polyethylene walk-
way. A two-step protocol will be used for the barefoot
pressure measurements, and each foot will be measured
3 times [23]. Each participant will be asked to walk at
their preferred speed and with their preferred step
length, in other words “as normally as possible”.E v e r y -
o n ew i l lh a v ea tl e a s tt w op r a c t i c er u n sp e rf o o tb e f o r e
the actual measurements are made. Participants are
asked to look straight ahead to prevent targeting; if tar-
geting is suspected, the measurement will be discarded
and a new run will be executed. For the in-shoe pressure
measurements an adequate size sensor-insole will be
placed in the shoe (99 sensors/insole, 100 Hz). Participants
will be asked to walk back and forth until twelve steps per
foot are obtained. First steps, final steps and steps while
turning will be excluded from the measurements.
Podiatric treatment
The participants (n = 100; see Sample size) in the inter-
vention group will be referred to a podiatrist to receive
usual podiatric care. The treatment may consist of shoe
advice, a silicone toe orthotico rc o r r e c t i v eo r t h o t i c sb y
means of an insole. Podiatrists are asked to follow the
treatment protocol recommended by podiatric depart-
ment of Fontys University of Applied Sciences. Each
participant will be advised to contact the podiatrist if
there are any problems with the treatment and an
appointment will be made with each participant to
examine progress and response to treatment after six to
eight weeks. If needed, the treatment will be adjusted.
The podiatrist will register details regarding the assess-
ment of the forefoot problem, the diagnosis and treat-
ment decisions on a standardised form.
Control condition
Participants (n = 100; see Sample size) in the control
group will receive a leaflet with shoe advice. The leaflet
has been developed in cooperation with the GPs of the
Academic Network of the VU University medical centre,
the podiatric school of Fontys University of Applied
Sciences and 8 podiatrists in the region. Shoe advice is
part of the lifestyle advice that is frequently given by
G P st op a t i e n t sw i t hf o o tp r o b l e m s[ 1 3 ] .D i s c u s s i o n s
with GPs prior to the trial indicated that this reflects a
common minimal and first treatment option; general
advice is given to wear well-fitting shoes of good quality
and sometimes the patient’s shoes are checked and com-
mented on. Some GPs give more specific advice to adapt
Figure 2 Foot manikin screenings questionnaire [5]. “I” is the inclusion area.
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In order to reflect usual care while ensuring optimal
contrast between the two treatment groups, we will ask
the GPs to refrain from specific individual advice. The
participants will be advised to compare their shoes with
recommended shoe wear presented in the leaflet and to
purchase better fitting shoes if their shoes are not com-
patible with these recommendations. A reimbursement
of € 25,- is given as an encouragement. All patients are
invited to contact the research group or their GP for
questions regarding the information leaflet. All partici-
pating GPs will receive a brief training session on how
to provide information based on the leaflet and how to
perform a shoe assessment.
Primary and secondary outcome measures
The primary outcome measures will be forefoot pain
intensity scored by the participant on an 11-point pain
numerical rating scale (PI-NRS, where 0 = no pain and
10 = worst possible pain), foot function using the 5
point Foot Function Index (FFI-5pt) and foot disability
using the FPDI [17,24,25]. The FFI-5pts has been trans-
lated into Dutch and validated for similar participants as
an interview schedule. The FPDI has been validated for
participants with foot problems but was not yet available
in Dutch. Within the scope of this trial the FPDI has
been translated into Dutch and will be validated accord-
ing to methods proposed by Beaton et al.[26]. Secondary
outcomes include social participation (Keele Assessment
of Participation[27]) and Quality of Life (SF-12). Both
primary and secondary outcome measures will be col-
lected at baseline and after 3, 6, 9, and 12 months. Data
on personal education and work history, shoe history
and co-morbidity[28] are collected at baseline as possi-
ble effect modifiers or confounders.
Process evaluation of podiatric treatment
Descriptive statistics will be used to describe the extent
to which assessment of the forefoot problem and podia-
tric treatment decisions concur with the protocol, and if
deviations (if any) can be explained.
For each patient in the podiatry treatment group, an
expert panel of a podiatrist, a lecturer of the podiatry
department of Fontys University for Applied Sciences and
a human movement scientist will evaluate whether the
diagnoses of the podiatrists are in accordance with the
results of their assessment, and whether adequate deci-
sions are made regarding treatment. For this evaluation,
the notes of the podiatrists and the results of the entrance
examination will be made available to the expert panel.
Sample size
There are no evidence-based estimates for clinically
important change in assessing forefoot pain or for
clinically relevant differences between interventions for
chronic foot pain. In a previous study it was estimated
that a reduction of approximately two points on an 11-
point pain intensity numerical rating scale represents a
clinically important improvement [29]. We assume that
the improvement in the podiatric treatment group will
be one point larger than the improvement in the control
group (a mean improvement of approximately 2 versus
1 point on the 0-11 point NRS, with an estimated stan-
dard deviation of 2.5). In this design the main question
is “whether the podiatric treatment is more effective
than the control treatment viz. a standardised shoe
advice”. Therefore we will perform a one-sided statistical
test with the null hypothesis that podiatric treatment
has either an equal outcome or a worse outcome as
compared to standardised shoe advice, both outcomes
having an equal clinical consequence [30].
In order to detect a 1 point difference in improvement
between the groups after 12 months with a one-sided
significance level of 0.05, and assuming a power of 0.8,
an ICC between podiatrists and GPs of 0.05, a correla-
tion of 0.50 between repeated measurements and a
minimum of 5 patients per care provider, we would
need complete data of 75 participants in each study
group. We will enrol 2 × 100 patients to allow for a
drop-out rate during follow-up of 25%. If every podia-
trist will treat a minimum of 5 patients, 15 podiatrists
will be needed to deliver the treatment in the entire
intervention group.
In 17 practices of the Academic Network, with a total
of n = 23,231 patients of 50 years or older, the diagnosis
“foot problems” (ICPC 17) or free text words indicating
foot problems were noted in the GP records of n = 497
patients within this age group. This incidence (21/1000)
is in accordance with a previous estimate of 17/1000
[31]). We expect that about one third of all consulters
presenting with foot problems have forefoot problems
that meet our criteria [2,5], and assuming about 50% of
these patients are eligible and willing to participate, a
practice with a population of average age distribution
can generate a minimum of 5 participants per year. This
means that we will need to recruit at least 40 practices
to participate in the trial to achieve the required number
of patients.
Treatment allocation and adherence
After providing informed consent, randomisation will be
performed based on an allocation schedule that is gener-
ated before the start of the trial by a computerised ran-
dom number generator using block randomisation with
blocks of 8 or 4 with pre-stratification for gender and
age (<75, ≥ 75). Since the age group ≥ 75 is expected to
be smaller, a block of 4 has been chosen to increase the
likelihood of equal distribution over the control and
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will prepare coded sealed envelopes containing the treat-
ment allocation. After baseline measurements the cor-
rect allocation envelope is opened by the participant.
The foot examiner will be blinded for the random
sequence and will not be informed of the block size
ensuring concealed allocation of treatment. All GPs will
be notified about the participants’ allocated treatment,
and will be asked to stimulate adherence to treatment
whenever the participant contacts the GP during the
intervention period. If symptoms do not improve despite
adherence to treatment during the 3 months following
randomisation, or with deterioration of the foot pro-
blem, the GP is free to provide another treatment or
refer the participant for further treatment elsewhere.
Data analysis
Multilevel analysis will be used to estimate the overall
effect of podiatric treatment as compared to standar-
dised shoe advice on the three primary outcome mea-
sures (PI-NTR, FFI-5pt and FPDI). Both clustering due
to participants being treated by podiatrists and cluster-
ing due to repeated measurements within the same indi-
viduals will be taken into account. Results will be
adjusted for differences in baseline similarity, if these
occur. The effect of interest is the treatment × time
interaction [32] where the primary focus will be on the
primary outcome measures at 3 and 12 months’ follow-
up. Differences in secondary outcome will be estimated
using similar statistical methods. All data will be ana-
lysed using an intention-to-treat approach. In all cases, a
significance level of 5% is pre-stipulated.
Discussion
In this paper we have described the design of a rando-
mised clinical trial to compare the effects of two com-
mon treatments for forefoot pain in older people.
During the design of this trial we had to make some
decisions which could potentially influence the trial
results. In order to explore the effectiveness of podiatric
treatment on forefoot problems, it would be optimal to
compare the podiatric treatment to a placebo treatment.
However, we aim to enrol patients who consult their GP
with a need for care of their forefoot problem. Conse-
quently, including a no-treatment arm would not be an
option in view of ethical reasons. GPs frequently only
provide lifestyle advice for foot problems including the
advice to wear well-fitting shoes [14]. By implementing
a standardised minimal intervention strategy by means
of a shoe leaflet we will reflect usual GP care for fore-
foot problems and not deny the participants a treatment
for their forefoot problem. Participants allocated to this
control treatment may be disappointed and we therefore
decided to offer partial reimbursement of the costs of
new shoes. We expect that this will reduce potential
contamination between the control and intervention
group and enhance treatment adherence in the control
group. We will investigate treatment adherence and
contamination in our process evaluation, perform a per
protocol analysis as a secondary analysis.
It is conceivable that wearing better fitting shoes has a
positive result on both foot function and foot pain. Never-
theless, in this study we are mainly interested to see if
referral to podiatric treatment provides a better outcome
than merely shoe advice. A problem we cannot resolve is
that all subjects will be aware of how they are being trea-
ted, either by receiving standardised shoe advice or podia-
tric treatment. The GPs will be instructed to stimulate
adherence to treatment whenever possible. If the foot pain
of participants in either group does not respond to treat-
ment after 3 months, the GPs are instructed to proceed
with providing an alternative treatment. Possible changes
of treatment are thoroughly documented.
Furthermore, although the podiatrists will be
requested to adhere to treatment protocol, it is evident
that podiatric treatment will be carried out by different
therapists. In this design a maximum of 5 or 6 patients
will be treated by a single podiatrist. This reduces the
possible influence of a therapist effect on the outcome
of the study, although the GPs would then need to refer
to more podiatrists than they normally do. A multilevel
analysis method will be used to estimate the ‘therapist
effect’ (variation in treatment effect due to differences in
podiatrists). Forefoot problems are very heterogeneous,
and the various problems may respond differently to
treatment. Although this will be analysed, the study
sample will prove too small to provide conclusive evi-
dence on any subgroup effects.
The strength of this study is that we created the
design for a pragmatic trial which will compare two
treatments that are most often advised by GPs: the
advice to wear well-fitting shoes and podiatric treat-
ment. Therefore, the results will contribute to clinical
decision making by primary care professionals in
patients with forefoot problems and it will provide infor-
mation on the potential benefits of a referral for podia-
tric care.
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